Evidence map›Paper›PMID 19717744›Full record

ArticleEukaryotic cell2009

Streptococcus mutans competence-stimulating peptide inhibits Candida albicans hypha formation.

Lucja M Jarosz, Dong Mei Deng, Henny C van der Mei, Wim Crielaard, Bastiaan P Krom

Abstract read
In one paragraph

Article in Eukaryotic cell, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Microorganisms · 2025
    Review
  5. Article
  6. Microorganisms · 2024
    Review
  7. Insights into the enigma of oral streptococci in carcinogenesis.Microbiology and molecular biology reviews : MMBR · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Roles ofFrontiers in cellular and infection microbiology · 2023
    Review
  12. Current and prospective therapeutic strategies: tacklingFrontiers in cellular and infection microbiology · 2023
    Review
  13. Article
  14. Virulence · 2022
    Article
  15. Article
  16. Effect of curcumin-encapsulated PluronicLasers in medical science · 2022
    Article
  17. Review
  18. Cross-kingdom interaction betweenFrontiers in microbiology · 2022
    Review
  19. Review
  20. Fungi-A Component of the Oral Microbiome Involved in Periodontal Diseases.Advances in experimental medicine and biology · 2022
    Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lucja M JaroszDepartment of Biomedical Engineering, the Kolff Institute, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands.
Dong Mei Deng
Henny C van der Mei
Wim Crielaard
Bastiaan P Krom

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oral cavity is colonized by microorganisms growing in biofilms in which interspecies interactions take place. Streptococcus mutans grows in biofilms on enamel surfaces and is considered one of the main etiological agents of human dental caries. Candida albicans is also commonly found in the human oral cavity, where it interacts with S. mutans. C. albicans is a polymorphic fungus, and the yeast-to-hypha transition is involved in virulence and biofilm formation. The aim of this study was to investigate interkingdom communication between C. albicans and S. mutans based on the production of secreted molecules. S. mutans UA159 inhibited C. albicans germ tube (GT) formation in cocultures even when physically separated from C. albicans. Only S. mutans spent medium collected in the early exponential phase (4-h-old cultures) inhibited the GT formation of C. albicans. During this phase, S. mutans UA159 produces a quorum-sensing molecule, competence-stimulating peptide (CSP). The role of CSP in inhibiting GT formation was confirmed by using synthetic CSP and a comC deletion strain of S. mutans UA159, which lacks the ability to produce CSP. Other S. mutans strains and other Streptococcus spp. also inhibited GT formation but to different extents, possibly reflecting differences in CSP amino acid sequences among Streptococcus spp. or differences in CSP accumulation in the media. In conclusion, CSP, an S. mutans quorum-sensing molecule secreted during the early stages of growth, inhibits the C. albicans morphological switch.

Indexed as

Down-RegulationBacterial ProteinsCandida albicansHumansHyphaeProtein TransportStreptococcal InfectionsStreptococcus mutansBacterial Proteinscompetence factor, Streptococcus

Identifiers

PMID19717744
PMCPMC2772401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.